A breakthrough genetic therapy for a rare form of blindness will cost $850,000 per patient, its maker announced on Wednesday.

Luxturna’s price is less than what many analysts and outside investors expected, and commercially insured patients likely won’t have to pay for the treatment.

Still, the price tag is higher than any other such treatments on the market.

Read more